checkAd
    LumiraDx Limited Registered (A) Aktie
    0,0170
     
    USD
    +10,68 %
    +0,0016 USD
    Letzter Kurs 27.04.24 Nasdaq OTC
    ISIN: KYG5709L1095 · WKN: A3C4C3 · SYM: LMDXF · Kaiman-Inseln

    Neueste Nachrichten

    LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th
    05.01.24 · globenewswire · LumiraDx Limited Registered (A)
    LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
    29.12.23 · globenewswire · LumiraDx Limited Registered (A)
    LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal
    27.10.23 · globenewswire · LumiraDx Limited Registered (A)
    LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub
    21.10.23 · globenewswire · LumiraDx Limited Registered (A)
    LumiraDx Reports Second Quarter 2023 Results
    24.08.23 · globenewswire · LumiraDx Limited Registered (A)
    LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24
    16.08.23 · globenewswire · LumiraDx Limited Registered (A)
    LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests
    31.07.23 · globenewswire · LumiraDx Limited Registered (A)
    LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test
    30.06.23 · globenewswire · LumiraDx Limited Registered (A)
    LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Tests
    20.06.23 · globenewswire · LumiraDx Limited Registered (A)
    LumiraDx Reports First Quarter 2023 Results
    16.05.23 · globenewswire · LumiraDx Limited Registered (A)
    LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 16
    09.05.23 · globenewswire · LumiraDx Limited Registered (A)